• This record comes from PubMed

The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome

. 2018 Jul ; 24 (3) : 447-456. [epub] 20170710

Language English Country Switzerland Media print-electronic

Document type Journal Article, Review

Links

PubMed 28695322
DOI 10.1007/s12253-017-0271-x
PII: 10.1007/s12253-017-0271-x
Knihovny.cz E-resources

The new WHO 2016 classification of renal neoplasia encounters the new entity called "clear cell papillary renal cell carcinoma" (ccpRCC). The ccpRCC has been long included as a subtype of clear cell RCC histotype and it actually ranges from 2 to 9% in different routinely available cohort of renal carcinomas. Of important note, ccpRCC does not show any recurrences or metastases or lymph-node invasion and the outcome is always good. We reviewed twenty-four publications with available follow-up for patients (no. 362) affected by clear cell papillary RCCs/renal adenomatoid tumours and notably ccpRCC harbors an indolent clinical behavior after a mean of 38 months (3,5 years) of follow-up. This paper reviews the histological, molecular and clinical features characterizing ccpRCC, with the goal of focusing the knowledge of the benign fashion of this new tumour entity, supporting the idea of a new renal cell adenoma recruited morphologically from ex conventional clear cell RCC tumours.

See more in PubMed

Am J Surg Pathol. 2006 Nov;30(11):1372-81 PubMed

Am J Surg Pathol. 2006 Feb;30(2):141-53 PubMed

Hum Pathol. 2014 Jun;45(6):1130-8 PubMed

Pathol Res Pract. 1993 Sep;189(8):951-6; discussion 957-9 PubMed

Hum Pathol. 2014 Sep;45(9):1966-72 PubMed

Int J Surg Pathol. 2016 May;24(3):207-12 PubMed

Histopathology. 2013 Feb;62(3):522-4 PubMed

Mod Pathol. 2015 Jun;28(6):845-853 PubMed

Am J Surg Pathol. 2015 Jul;39(7):889-901 PubMed

Am J Surg Pathol. 2013 Oct;37(10):1469-89 PubMed

Pathology. 2008 Aug;40(5):481-6 PubMed

Korean J Pathol. 2012 Dec;46(6):541-7 PubMed

Histopathology. 2014 Jun;64(7):1032-6 PubMed

Hum Pathol. 2009 Mar;40(3):425-9 PubMed

Mod Pathol. 2011 Sep;24(9):1207-20 PubMed

Am J Surg Pathol. 2010 Nov;34(11):1608-21 PubMed

Hum Pathol. 2014 Jan;45(1):59-64 PubMed

Am J Surg Pathol. 2015 Dec;39(12):1621-34 PubMed

Mod Pathol. 2013 May;26(5):697-708 PubMed

Int J Clin Exp Pathol. 2015 May 01;8(5):4595-9 PubMed

Pathol Int. 2009 Sep;59(9):689-91 PubMed

Ann Diagn Pathol. 2000 Oct;4(5):311-5 PubMed

Virchows Arch. 2011 Oct;459(4):457-63 PubMed

Virchows Arch. 2009 Jan;454(1):89-99 PubMed

Eur Urol. 2016 Jul;70(1):93-105 PubMed

Am J Surg Pathol. 2016 Feb;40(2):141-54 PubMed

Am J Surg Pathol. 2008 Dec;32(12):1780-6 PubMed

Ann Diagn Pathol. 2012 Dec;16(6):470-6 PubMed

Histopathology. 2011 Jun;58(7):1064-71 PubMed

Mod Pathol. 2014 May;27(5):765-74 PubMed

Am J Surg Pathol. 2008 Aug;32(8):1239-45 PubMed

Int J Surg Pathol. 2012 Feb;20(1):19-28 PubMed

Am J Surg Pathol. 2015 Jul;39(7):873-88 PubMed

J Clin Pathol. 2016 Jun;69(6):547-50 PubMed

Int J Clin Exp Pathol. 2013 Nov 15;6(12 ):2936-42 PubMed

Mod Pathol. 2014 Feb;27(2):222-30 PubMed

Am J Surg Pathol. 2013 Aug;37(8):1131-9 PubMed

J Pathol. 2014 Jan;232(1):32-42 PubMed

Virchows Arch. 2014 Jun;464(6):709-16 PubMed

Pathol Res Pract. 2014 Apr;210(4):234-41 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...